Multiple sclerosis: Investigation into side effects of switching patients to natalizumab biosimilar. Mahase E. BMJ 2025;388:r403.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mahase E. Multiple sclerosis: Investigation into side effects of switching patients to natalizumab biosimilar. BMJ 2025;388:r403.
PMID: 40010806